Hypoxia inducible BHLHB2 is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma
Authors:
- Carolin Reiser-ErkanCRCarolin Reiser-Erkan
- Mert ErkanMEMert Erkan
- Jörg KleeffJörg Kleeff
- 1 October 2010
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 401 (3) , 422-428
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Organ-, inflammation- and cancer specific transcriptional fingerprints of pancreatic and hepatic stellate cellsMolecular Cancer, 2010
- The Hypoxia-Regulated Transcription Factor DEC1 (Stra13, SHARP-2) and Its Expression in Gastric CancerOMICS: A Journal of Integrative Biology, 2009
- Ex vivo chemosensitivity testing and gene expression profiling predict response towards adjuvant gemcitabine treatment in pancreatic cancerBritish Journal of Cancer, 2008
- Altered Stra13 and Dec2 circadian gene expression in hypoxic cellsBiochemical and Biophysical Research Communications, 2008
- Cannabinoids Reduce Markers of Inflammation and Fibrosis in Pancreatic Stellate CellsPLOS ONE, 2008
- Basic‐helix‐loop‐helix (bHLH) transcription factor DEC2 negatively regulates vascular endothelial growth factor expressionGenes to Cells, 2008
- Mononuclear cells modulate the activity of pancreatic stellate cells which in turn promote fibrosis and inflammation in chronic pancreatitisJournal of Translational Medicine, 2007
- Identification of Genes Differentially Induced by Hypoxia in Pancreatic Cancer CellsBiochemical and Biophysical Research Communications, 2001
- Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profilingOncogene, 2000
- Identification of new actin-associated polypeptides that are modified by viral transformation and changes in cell shape.Journal of Cell Biology, 1988